Skip to main content
Top
Published in: AIDS and Behavior 1/2017

01-01-2017 | Original Paper

Disclosure History Among Persons Initiating Antiretroviral Treatment at Six HIV Clinics in Oromia, Ethiopia, 2012–2013

Authors: Tsigereda Gadisa, Olga Tymejczyk, Sarah Gorrell Kulkarni, Susie Hoffman, Maria Lahuerta, Robert H. Remien, Muluneh Yigzaw, Shalo Daba, Batya Elul, Denis Nash, Zenebe Melaku

Published in: AIDS and Behavior | Issue 1/2017

Login to get access

Abstract

HIV status disclosure can help patients obtain support which may influence treatment adherence and subsequent healthcare needs. We examined the extent of disclosure and correlates of non-disclosure among 1180 adults newly initiating antiretroviral treatment (ART). While 91 % of those in a relationship shared their status with their partners, 14 % of the overall sample had not disclosed to anyone. Non-disclosure was positively associated with older age; control over household resources; and concerns about unintended disclosure, life disruptions, and family reactions. Knowing other HIV-positive people and longer time since diagnosis were associated with lower odds of non-disclosure. Most respondents reporting disclosure experienced supportive responses, frequently including decision to get an HIV test by confidants who had not known their own status. Although HIV status disclosure prior to ART initiation was high, some individuals cited concerns about unintended disclosure, gossip, and partner violence, and may benefit from additional disclosure support.
Literature
1.
go back to reference Joint United Nations Programme on HIV/AIDS. Opening up the HIV/AIDS epidemic. Guidance on encouraging beneficial disclosure, ethical partner counselling and appropriate use of HIV case-reporting. Geneva: World Health Organization. 2000. Joint United Nations Programme on HIV/AIDS. Opening up the HIV/AIDS epidemic. Guidance on encouraging beneficial disclosure, ethical partner counselling and appropriate use of HIV case-reporting. Geneva: World Health Organization. 2000.
2.
go back to reference Southern African AIDS Trust. Guidelines for Counseling on Disclosure of HIV Status. Southern African AIDS Trust. 2011. Southern African AIDS Trust. Guidelines for Counseling on Disclosure of HIV Status. Southern African AIDS Trust. 2011.
3.
go back to reference Petrak JA, Doyle A-M, Smith A, Skinner C, Hedge B. Factors associated with self-disclosure of HIV serostatus to significant others. Br J Health Psychol. 2001;6(1):69.CrossRefPubMed Petrak JA, Doyle A-M, Smith A, Skinner C, Hedge B. Factors associated with self-disclosure of HIV serostatus to significant others. Br J Health Psychol. 2001;6(1):69.CrossRefPubMed
4.
go back to reference Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004 Apr;82(4):299–307.PubMedPubMedCentral Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004 Apr;82(4):299–307.PubMedPubMedCentral
5.
go back to reference Deribe K, Woldemichael K, Njau BJ, Yakob B, Biadgilign S, Amberbir A. Gender differences regarding barriers and motivators of HIV status disclosure among HIV-positive service users. SAHARA J. 2010;7(1):30–9.CrossRefPubMed Deribe K, Woldemichael K, Njau BJ, Yakob B, Biadgilign S, Amberbir A. Gender differences regarding barriers and motivators of HIV status disclosure among HIV-positive service users. SAHARA J. 2010;7(1):30–9.CrossRefPubMed
6.
go back to reference Deribe K, Woldemichael K, Wondafrash M, Haile A, Amberbir A. Disclosure experience and associated factors among HIV positive men and women clinical service users in Southwest Ethiopia. BMC Public Health. 2008;8:81.CrossRefPubMedPubMedCentral Deribe K, Woldemichael K, Wondafrash M, Haile A, Amberbir A. Disclosure experience and associated factors among HIV positive men and women clinical service users in Southwest Ethiopia. BMC Public Health. 2008;8:81.CrossRefPubMedPubMedCentral
7.
go back to reference Gari T, Habte D, Markos E. HIV positive status disclosure among women attending art clinic at Hawassa University Referral Hospital, South Ethiopia. East Afr J Public Health. 2010 Mar;7(1):87–91.PubMed Gari T, Habte D, Markos E. HIV positive status disclosure among women attending art clinic at Hawassa University Referral Hospital, South Ethiopia. East Afr J Public Health. 2010 Mar;7(1):87–91.PubMed
8.
go back to reference Genet M, Sebsibie G, Gultie T. Disclosure of HIV seropositive status to sexual partners and its associated factors among patients attending antiretroviral treatment clinic follow up at Mekelle Hospital, Ethiopia: a cross sectional study. BMC Res Notes. 2015;8:109.CrossRefPubMedPubMedCentral Genet M, Sebsibie G, Gultie T. Disclosure of HIV seropositive status to sexual partners and its associated factors among patients attending antiretroviral treatment clinic follow up at Mekelle Hospital, Ethiopia: a cross sectional study. BMC Res Notes. 2015;8:109.CrossRefPubMedPubMedCentral
9.
go back to reference Kassaye KD, Lingerh W, Dejene Y. Determinants and outcomes of disclosing HIV-sero positive status to sexual partners among women in Mettu and Gore towns, Illubabor Zone southwest Ethiopia. Ethiop J Health Dev. 2005;19(2):126–31.CrossRef Kassaye KD, Lingerh W, Dejene Y. Determinants and outcomes of disclosing HIV-sero positive status to sexual partners among women in Mettu and Gore towns, Illubabor Zone southwest Ethiopia. Ethiop J Health Dev. 2005;19(2):126–31.CrossRef
10.
go back to reference Reda AA, Biadgilign S, Deribe K, Deribew A. HIV-positive status disclosure among men and women receiving antiretroviral treatment in eastern Ethiopia. AIDS Care. 2013 Aug;25(8):956–60.CrossRefPubMed Reda AA, Biadgilign S, Deribe K, Deribew A. HIV-positive status disclosure among men and women receiving antiretroviral treatment in eastern Ethiopia. AIDS Care. 2013 Aug;25(8):956–60.CrossRefPubMed
11.
go back to reference Seid M, Wasie B, Admassu M. Disclosure of HIV positive result to a sexual partner among adult clinical service users in Kemissie district, northeast Ethiopia. Afr J Reprod Health. 2012 Mar;16(1):97–104.PubMed Seid M, Wasie B, Admassu M. Disclosure of HIV positive result to a sexual partner among adult clinical service users in Kemissie district, northeast Ethiopia. Afr J Reprod Health. 2012 Mar;16(1):97–104.PubMed
12.
go back to reference Alemayehu M, Aregay A, Kalayu A, Yebyo H. HIV disclosure to sexual partner and associated factors among women attending ART clinic at Mekelle hospital, Northern Ethiopia. BMC Public Health. 2014;14:746.CrossRefPubMedPubMedCentral Alemayehu M, Aregay A, Kalayu A, Yebyo H. HIV disclosure to sexual partner and associated factors among women attending ART clinic at Mekelle hospital, Northern Ethiopia. BMC Public Health. 2014;14:746.CrossRefPubMedPubMedCentral
13.
go back to reference Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA J Am Med Assoc. 2006 Aug 9;296(6):679–90.CrossRef Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA J Am Med Assoc. 2006 Aug 9;296(6):679–90.CrossRef
14.
go back to reference Skhosana N, Struthers H, Gray G, McIntyre J. HIV disclosure and other factors that impact on adherence to antiretroviral therapy: the case of Soweto, South Africa. Afr J AIDS Res. 2006;5(1):17–26.CrossRefPubMed Skhosana N, Struthers H, Gray G, McIntyre J. HIV disclosure and other factors that impact on adherence to antiretroviral therapy: the case of Soweto, South Africa. Afr J AIDS Res. 2006;5(1):17–26.CrossRefPubMed
15.
go back to reference Kalichman SC, Nachimson D. Self-efficacy and disclosure of HIV-positive serostatus to sex partners. Health Psychol. 1999 May;18(3):281–7.CrossRefPubMed Kalichman SC, Nachimson D. Self-efficacy and disclosure of HIV-positive serostatus to sex partners. Health Psychol. 1999 May;18(3):281–7.CrossRefPubMed
16.
go back to reference Stirratt MJ, Remien RH, Smith A, Copeland OQ, Dolezal C, Krieger D. The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS Behav. 2006 Sep;10(5):483–93.CrossRefPubMed Stirratt MJ, Remien RH, Smith A, Copeland OQ, Dolezal C, Krieger D. The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS Behav. 2006 Sep;10(5):483–93.CrossRefPubMed
17.
go back to reference Waddell EN, Messeri PA. Social support, disclosure, and use of antiretroviral therapy. AIDS Behav. 2006 May;10(3):263–72.CrossRefPubMed Waddell EN, Messeri PA. Social support, disclosure, and use of antiretroviral therapy. AIDS Behav. 2006 May;10(3):263–72.CrossRefPubMed
18.
go back to reference Central Statistical Agency [Ethiopia] and ICF International. Ethiopia Demographic and Health Survey. Addis Ababa: Central Statistical Agency and ICF International. 2011. Central Statistical Agency [Ethiopia] and ICF International. Ethiopia Demographic and Health Survey. Addis Ababa: Central Statistical Agency and ICF International. 2011.
19.
go back to reference Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2013. Geneva. 2013. 978-92-9253-032-7. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2013. Geneva. 2013. 978-92-9253-032-7.
20.
go back to reference Federal HIV/AIDS Prevention and Control Office. Federal Ministry of Health. Guidelines for Implementation of the Antiretroviral Therapy Programme in Ethiopia. Federal HIV/AIDS Prevention and Control Office. Federal Ministry of Health. 2007 Federal HIV/AIDS Prevention and Control Office. Federal Ministry of Health. Guidelines for Implementation of the Antiretroviral Therapy Programme in Ethiopia. Federal HIV/AIDS Prevention and Control Office. Federal Ministry of Health. 2007
21.
22.
go back to reference Makin JD, Forsyth BW, Visser MJ, Sikkema KJ, Neufeld S, Jeffery B. Factors affecting disclosure in South African HIV-positive pregnant women. AIDS patient care and STDs. 2008 Nov;22(11):907–16.CrossRefPubMedPubMedCentral Makin JD, Forsyth BW, Visser MJ, Sikkema KJ, Neufeld S, Jeffery B. Factors affecting disclosure in South African HIV-positive pregnant women. AIDS patient care and STDs. 2008 Nov;22(11):907–16.CrossRefPubMedPubMedCentral
23.
go back to reference Kulkarni S, Hoffman S, Gadisa T, Melaku Z, Fantehun M, Yigzaw M, et al. Identifying perceived barriers along the HIV care continuum: findings from providers, peer educators, and observations of provider-patient interactions in Ethiopia. J Intern Assoc Provid AIDS Care. 2015. doi:10.1177/2325957415593635. Kulkarni S, Hoffman S, Gadisa T, Melaku Z, Fantehun M, Yigzaw M, et al. Identifying perceived barriers along the HIV care continuum: findings from providers, peer educators, and observations of provider-patient interactions in Ethiopia. J Intern Assoc Provid AIDS Care. 2015. doi:10.​1177/​2325957415593635​.
24.
go back to reference Akani CI, Erhabor O. Rate, pattern and barriers of HIV serostatus disclosure in a resource-limited setting in the Niger delta of Nigeria. Trop Doct. 2006;36(2):87–9.CrossRefPubMed Akani CI, Erhabor O. Rate, pattern and barriers of HIV serostatus disclosure in a resource-limited setting in the Niger delta of Nigeria. Trop Doct. 2006;36(2):87–9.CrossRefPubMed
25.
go back to reference Antelman G, Smith Fawzi MC, Kaaya S, Mbwambo J, Msamanga GI, Hunter DJ, et al. Predictors of HIV-1 serostatus disclosure: a prospective study among HIV-infected pregnant women in Dar es Salaam, Tanzania. AIDS (London, England). 2001;15(14):1865–74. Antelman G, Smith Fawzi MC, Kaaya S, Mbwambo J, Msamanga GI, Hunter DJ, et al. Predictors of HIV-1 serostatus disclosure: a prospective study among HIV-infected pregnant women in Dar es Salaam, Tanzania. AIDS (London, England). 2001;15(14):1865–74.
26.
go back to reference Ezegwui HU, Nwogu-Ikojo EE, Enwereji JO, Dim CC. HIV serostatus disclosure pattern among pregnant women in Enugu, Nigeria. J Biosoc Sci. 2009 Nov;41(6):789–98.CrossRefPubMed Ezegwui HU, Nwogu-Ikojo EE, Enwereji JO, Dim CC. HIV serostatus disclosure pattern among pregnant women in Enugu, Nigeria. J Biosoc Sci. 2009 Nov;41(6):789–98.CrossRefPubMed
27.
go back to reference Kadowa I, Nuwaha F. Factors influencing disclosure of HIV positive status in Mityana district of Uganda. Afr Health Sci. 2009;9(1):26–33.PubMedPubMedCentral Kadowa I, Nuwaha F. Factors influencing disclosure of HIV positive status in Mityana district of Uganda. Afr Health Sci. 2009;9(1):26–33.PubMedPubMedCentral
28.
go back to reference Longinetti E, Santacatterina M, El-Khatib Z. Gender perspective of risk factors associated with disclosure of HIV status, a cross-sectional study in Soweto, South Africa. PLoS ONE. 2014;9(4):e95440.CrossRefPubMedPubMedCentral Longinetti E, Santacatterina M, El-Khatib Z. Gender perspective of risk factors associated with disclosure of HIV status, a cross-sectional study in Soweto, South Africa. PLoS ONE. 2014;9(4):e95440.CrossRefPubMedPubMedCentral
29.
go back to reference Maman S, Mbwambo JK, Hogan NM, Weiss E, Kilonzo GP, Sweat MD. High rates and positive outcomes of HIV-serostatus disclosure to sexual partners: reasons for cautious optimism from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania. AIDS Behav. 2003 Dec;7(4):373–82.CrossRefPubMed Maman S, Mbwambo JK, Hogan NM, Weiss E, Kilonzo GP, Sweat MD. High rates and positive outcomes of HIV-serostatus disclosure to sexual partners: reasons for cautious optimism from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania. AIDS Behav. 2003 Dec;7(4):373–82.CrossRefPubMed
30.
go back to reference Ndiaye C, Boileau C, Zunzunegui MV, Koala S, Aboubacrine SA, Niamba P, et al. Gender-related factors influencing HIV serostatus disclosure in patients receiving HAART in West Africa. World Health Popul. 2008;10(3):43–54.PubMed Ndiaye C, Boileau C, Zunzunegui MV, Koala S, Aboubacrine SA, Niamba P, et al. Gender-related factors influencing HIV serostatus disclosure in patients receiving HAART in West Africa. World Health Popul. 2008;10(3):43–54.PubMed
31.
go back to reference Farquhar C, Ngacha D, Bosire R, Nduati R, Kreiss J, John G, editors. Prevalence and correlates of partner notification regarding HIV-1 in an antenatal setting in Nairobi, Kenya. XIII International AIDS Conference; 2000. Farquhar C, Ngacha D, Bosire R, Nduati R, Kreiss J, John G, editors. Prevalence and correlates of partner notification regarding HIV-1 in an antenatal setting in Nairobi, Kenya. XIII International AIDS Conference; 2000.
32.
go back to reference Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2012 Aug 11;365(6):493–505.CrossRef Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2012 Aug 11;365(6):493–505.CrossRef
Metadata
Title
Disclosure History Among Persons Initiating Antiretroviral Treatment at Six HIV Clinics in Oromia, Ethiopia, 2012–2013
Authors
Tsigereda Gadisa
Olga Tymejczyk
Sarah Gorrell Kulkarni
Susie Hoffman
Maria Lahuerta
Robert H. Remien
Muluneh Yigzaw
Shalo Daba
Batya Elul
Denis Nash
Zenebe Melaku
Publication date
01-01-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1290-4

Other articles of this Issue 1/2017

AIDS and Behavior 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.